SDIX is a biotechnology company with a core expertise in creating better antigens, better antibodies and better assays for the pharmaceutical and biotechnology markets. For over 25 years, SDIX has been a leading immuno-solutions company, developing results-oriented and innovative antibody-based solutions that enable customers to meet high performance research, diagnostic and commercialization objectives.
In July 2013, SDIX’s Life Science assets were acquired by OriGene Technologies, Inc. SDIX, LLC, is now operating as a wholly owned subsidiary of OriGene Technologies. The combination of SDIX’s core Life Science business and Advanced GAT technologies with OriGene’s genome-wide research tools and technology platform will result in an expanded portfolio of products and services.
SDIX LLC will continue to operate from its facility in Newark, Delaware, and Windham, Maine. If you have any questions, please contact your Account Manager or Customer Service.